News

Filter

Current filters:

HematologyLicensing

1 to 9 of 16 results

Takeda ends partnership with AMAG Pharma on Rienso/Feraheme

Takeda ends partnership with AMAG Pharma on Rienso/Feraheme

30-12-2014

Japan’s largest drugmaker Takeda Pharmaceutical has entered into an agreement with US drugmaker AMAG…

AMAG PharmaceuticalsCanadaEuropeFerahemeHematologyLicensingNephrology and HepatologyPharmaceuticalRiensoTakeda Pharmaceutical

Spark Thera in potential $280 million hemophilia B deal with Pfizer

Spark Thera in potential $280 million hemophilia B deal with Pfizer

10-12-2014

US gene therapy start up Spark Therapeutics has entered into a global collaboration with pharma giant…

BiotechnologyHematologyLicensingPfizerSpark TherapeuticsSPK-RPE65USA

Onxeo receives $25M milestone payment from Spectrum on Beleodaq

14-11-2014

Onxeo, created by a merger between French company BioAlliance Pharma, and Danish biopharmaceutical company…

BeleodaqBiotechnologyFinancialHematologyLicensingOncologyOnxeoSpectrum PharmaceuticalsUSA

Geron in up to $935 million deal with Janssen for imetelstat

Geron in up to $935 million deal with Janssen for imetelstat

14-11-2014

Geron Corp has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech,…

BiotechnologyGeron CorpGlobalHematologyimetelstatJanssen BiotechJohnson & JohnsonLicensingOncology

TG Therapeutics takes up option on PI3K-Delta inhibitor, TGR-1202

23-09-2014

US development stage company TG Therapeutics says it has exercised its option to license the global rights…

HematologyLicensingOncologyPharmaceuticalRhizen PharmaceuticalsTG TherapeuticsTGR-1202

Swedish Orphan Biovitrum adds new molecule to its hemophilia collaboration with Biogen Idec

Swedish Orphan Biovitrum adds new molecule to its hemophilia collaboration with Biogen Idec

19-09-2014

Nordic biotech firm Swedish Orphan Biovitrum has added the preclinical fusion molecule rFVIIIFc-XTEN-vWF…

Biogen IdecBiotechnologyHematologyLicensingSobiSweden

Bayer strikes deal with Dimension Therapeutics to develop hemophilia A gene therapy

23-06-2014

USA-based venture capital;-backed biotech Dimension Therapeutics has entered into a collaboration with…

BayerBiotechnologyDimension TheapeuticsHematologyLicensingResearch

Biogen Idec exercises option for Amunix’ XTENylated Factor VIII

21-04-2014

US privately-held biotech firm Amunix Operating says that Biogen Idec has exercised its option to enter…

AmunixBiogen IdecBiotechnologyHematologyLicensing

1 to 9 of 16 results

Back to top